Celldex Therapeutics News

News on Celldex Therapeutics (Ticker: CLDX) continually updated from thousands of sources around the net.

Thursday May 24 | Wall St. Cheat Sheet

Analyst Insights: Celldex, InterMune, American Tower, Thermo Fisher, Jiayuan.com May 24th

Celldex Therapeutics, Inc. : Oppenheimer believes that data released by Celldex showed that the company's CDX-011 drug benefited patients with a large amount of cancerous cells, as it's designed to do.

Comment?

Wed May 23, 2012

Drugs.com

Celldex's CDX-011 Demonstrates High Response Rates in Patients with...

Celldex's CDX-011 Demonstrates High Response Rates in Patients with Metastatic Breast Cancer Expressing Elevated Levels of GPNMB and in Triple Negative Disease NEEDHAM, Mass.-- --May 23, 2012 - Celldex Therapeutics, Inc.

Comment?

Fri May 18, 2012

Freshnews

Celldex Therapeutics to Host Call to Announce Topline Results from...

NEEDHAM, Mass. -- -- Celldex Therapeutics, Inc. will host a conference call at 4:30 P.M. Eastern Time on Wednesday, May 23, 2012 to announce interim, topline results of the Phase 2b EMERGE study of CDX-011 in patients with advanced breast cancer.

Comment?

Tue May 15, 2012

BioSpace

Celldex Therapeutics, Inc. Added to Biotechnology Index

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia NEEDHAM, Mass.-- --Celldex Therapeutics, Inc.

Comment?

Thu May 03, 2012

BioSpace

Celldex Therapeutics, Inc. Reports First Quarter 2012 Financial Results

Comment?

Tue May 01, 2012

Drugs.com

Celldex Announces Plans to Release Topline Results from the EMERGE Study in Advanced Breast Cancer

NEEDHAM, Mass.-- --May 1, 2012 - Celldex Therapeutics, Inc. today announced that interim, topline results of the Phase 2b EMERGE study of CDX-011 in patients with advanced breast cancer will be presented in a webcast on May 23, 2012.

Comment?